Nicardipine Hydrochloride recalls
Nicardipine Hydrochloride products have been recalled 7 times, most recently on 26 Aug 2026. The recalling company is usually American Regent. The most common reason is sterility.
Total recalls7since 2013
Last 12 months1reported
Class I00% of total
Ongoing5latest 26 Aug 2026
Recalls per month, last 24 months
click a bar for that monthSeverity split
Class I 0 0%Class II 6 86%Class III 1 14%
Why nicardipine hydrochloride is recalled
Companies
Product types
By year
Ongoing nicardipine hydrochloride recalls
5 active| Reported | Class | Recall | Company | Reason | Where |
|---|---|---|---|---|---|
| Drug | CLASS II | niCARdipine Hydrochloride Injection, USP, 25 mg/ 5 mg/mL) recalledNicardipine Hydrochloride | American Regent | Particulate Matter | Nationwide |
| Drug | CLASS II | niCARdipine Hydrochloride Injection recalled by American RegentNicardipine Hydrochloride | American Regent | Sterility | Nationwide |
| Drug | CLASS II | niCARdipine Hydrochloride Injection recalled by American RegentNicardipine Hydrochloride | American Regent | Sterility | Nationwide |
| Drug | CLASS II | Nicardipine Hydrochloride Injection 5mg/mL), US, 25mg per Vial recalledNicardipine Hydrochloride | Eugia US | Potency & Assay | Nationwide |
| Drug | CLASS II | Nicardipine Hydrochloride Injection, USP 25mg/mL 5 mg/mL) vials recalledNicardipine Hydrochloride | Eugia US | Potency & Assay | Nationwide |
All nicardipine hydrochloride recalls, newest first
7 totalAbout this list
Records come from FDA enforcement reports and USDA FSIS notices, grouped by normalised name. A company operating under several names may appear more than once.